Singular Genomics Systems, Inc. (OMIC)

Singular Genomics Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-94.82	-90.88	-98.77	-27.95	-12.32
Depreciation & Amortization	7.22	6.03	1.13	0.64	0.35
Share-Based Compensation	11.4	13.67	9.23	1.06	0.17
Other Operating Activities	2.55	-15.92	36.71	1.37	0.41
Operating Cash Flow	-73.65	-87.09	-51.7	-24.87	-11.4
Capital Expenditures	-0.97	-6.02	-4.86	-1.38	-0.8
Change in Investments	14.78	-33.54	-126	25.39	-30.7
Investing Cash Flow	13.81	-39.57	-130.86	24.01	-31.5
Share Issuance / Repurchase	0.7	0.9	241.53	0.05	0.02
Debt Issued / Paid	0	0	130.6	7.5	2.46
Other Financing Activities	-	-	-	-0.03	44.82
Financing Cash Flow	0.7	0.9	372.13	7.52	47.3
Net Cash Flow	-59.14	-125.76	189.57	6.65	4.41
Free Cash Flow	-74.62	-93.12	-56.57	-26.25	-12.2
Free Cash Flow Margin	-2563.28%	-12172.03%	-	-	-
Free Cash Flow Per Share	-1.02	-1.31	-1.20	-2.48	-1.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).